http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07173127-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33dafb5bbc2ec47ebcb7becbbe60f704 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C259-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 |
filingDate | 1993-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8641c8cfa525af75340bec29875e26ac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c543bcd4dd206d726450f3e3f6885a56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70d4fb47623aaf01c6f788dfb4032f57 |
publicationDate | 1995-07-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-H07173127-A |
titleOfInvention | Hydroxamic acid derivative and elastase inhibitor containing the same as active ingredient |
abstract | (57) [Summary] (Modified) [Structure] A hydroxamic acid derivative of the formula (I) and a pharmaceutically acceptable salt thereof. 【effect】 (In the formula, R 1 and R 2 each have 3 to 10 carbon atoms. Represents an alkyl group, R 3 represents a hydrogen atom, a carboxyl group, an alkyloxycarbonyl group or benzyloxycarbonyl group, R 4 is a hydrogen atom, 1 to carbon atoms 5 represents a lower alkyl group or a benzyl group. ) These have excellent human leukocyte elastase inhibitory action. Therefore, a pharmaceutical composition containing the compound as an active ingredient is useful as a human leukocyte elastase inhibitor. |
priorityDate | 1993-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 73.